-
Je něco špatně v tomto záznamu ?
Quality of Life and Treatment Satisfaction in Participants with Maturity-Onset Diabetes of the Young: A Comparison to Other Major Forms of Diabetes
P. Dusatkova, M. Pavlikova, A. Spirkova, L. Elblova, DJ. Zdarska, K. Rozenkova, J. Hron, Z. Sumnik, O. Cinek, J. Lebl, S. Pruhova
Jazyk angličtina Země Německo
Typ dokumentu srovnávací studie, časopisecké články
Grantová podpora
Ministry of Health of the Czech Republic
NV18-01-00078
PubMed
32722819
DOI
10.1055/a-1200-1482
Knihovny.cz E-zdroje
- MeSH
- diabetes mellitus 1. typu psychologie terapie MeSH
- diabetes mellitus 2. typu psychologie terapie MeSH
- dítě MeSH
- dospělí MeSH
- kvalita života * MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- spokojenost pacientů * MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- Publikační typ
- časopisecké články MeSH
- srovnávací studie MeSH
AIMS: We investigated the quality of life (QoL), treatment satisfaction and perception of genetic results in participants with Maturity-Onset Diabetes of the Young (MODY) and compared the results with those of subjects with type 1 (T1D) or type 2 (T2D) diabetes. METHODS: A total of 162 adults with GCK-MODY, 62 with HNF1A-MODY and 29 with HNF4A-MODY answered the questionnaire Audit of Diabetes Dependent Quality of Life, the Diabetes Treatment Satisfaction Questionnaire and non-validated instrument examining the respondent's perception of the genetic results. Data from GCK-MODY patients were compared with 84 participants with T2D and HNF-MODY subjects were compared with 81 participants having T1D. RESULTS: Higher age (p=0.004), higher haemoglobin A1c (p=0.026) and medication (p=0.019) were associated with lower general QoL in GCK-MODY patients. In HNF-MODY patients, lower general QoL was associated with a longer time since diagnosis (p=0.005), worse haemoglobin bA1c (p=0.006) and insulin treatment (p=0.019). Similar numbers of participants with GCK- and HNF-MODY considered the genetic diagnosis of MODY to be positive, negative and without significance. The patient with GCK-MODY did not differ from those with T2D in terms of their QoL, but they were less satisfied with their treatment (p<0.001). QoL was better in patients with HNF-MODY compared with patients with T1D (p=0.006), and they did not differ in terms of treatment satisfaction. CONCLUSIONS: QoL was affected in both GCK-MODY and HNF-MODY subjects. Apprehension of genetic diagnosis was not single-valued in MODY respondents.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22011141
- 003
- CZ-PrNML
- 005
- 20220506130517.0
- 007
- ta
- 008
- 220425s2022 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1055/a-1200-1482 $2 doi
- 035 __
- $a (PubMed)32722819
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Dusatkova, Petra $u Department of Paediatrics, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/0000000286479088
- 245 10
- $a Quality of Life and Treatment Satisfaction in Participants with Maturity-Onset Diabetes of the Young: A Comparison to Other Major Forms of Diabetes / $c P. Dusatkova, M. Pavlikova, A. Spirkova, L. Elblova, DJ. Zdarska, K. Rozenkova, J. Hron, Z. Sumnik, O. Cinek, J. Lebl, S. Pruhova
- 520 9_
- $a AIMS: We investigated the quality of life (QoL), treatment satisfaction and perception of genetic results in participants with Maturity-Onset Diabetes of the Young (MODY) and compared the results with those of subjects with type 1 (T1D) or type 2 (T2D) diabetes. METHODS: A total of 162 adults with GCK-MODY, 62 with HNF1A-MODY and 29 with HNF4A-MODY answered the questionnaire Audit of Diabetes Dependent Quality of Life, the Diabetes Treatment Satisfaction Questionnaire and non-validated instrument examining the respondent's perception of the genetic results. Data from GCK-MODY patients were compared with 84 participants with T2D and HNF-MODY subjects were compared with 81 participants having T1D. RESULTS: Higher age (p=0.004), higher haemoglobin A1c (p=0.026) and medication (p=0.019) were associated with lower general QoL in GCK-MODY patients. In HNF-MODY patients, lower general QoL was associated with a longer time since diagnosis (p=0.005), worse haemoglobin bA1c (p=0.006) and insulin treatment (p=0.019). Similar numbers of participants with GCK- and HNF-MODY considered the genetic diagnosis of MODY to be positive, negative and without significance. The patient with GCK-MODY did not differ from those with T2D in terms of their QoL, but they were less satisfied with their treatment (p<0.001). QoL was better in patients with HNF-MODY compared with patients with T1D (p=0.006), and they did not differ in terms of treatment satisfaction. CONCLUSIONS: QoL was affected in both GCK-MODY and HNF-MODY subjects. Apprehension of genetic diagnosis was not single-valued in MODY respondents.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a diabetes mellitus 1. typu $x psychologie $x terapie $7 D003922
- 650 _2
- $a diabetes mellitus 2. typu $x psychologie $x terapie $7 D003924
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a spokojenost pacientů $7 D017060
- 650 12
- $a kvalita života $7 D011788
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pavlikova, Marketa $u Department of Probability and Mathematical Statistics, Faculty of Mathematics and Physics, Charles University, Prague, Czech Republic
- 700 1_
- $a Spirkova, Alena $u Department of Paediatrics, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Elblova, Lenka $u Department of Paediatrics, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Zdarska, Denisa Janickova $u Department of Internal Medicine, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Rozenkova, Klara $u Department of Paediatrics, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Hron, Jakub $u Diabet2, Prague, Czech Republic
- 700 1_
- $a Sumnik, Zdenek $u Department of Paediatrics, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Cinek, Ondrej $u Department of Paediatrics, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Lebl, Jan $u Department of Paediatrics, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Pruhova, Stepanka $u Department of Paediatrics, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
- 773 0_
- $w MED00009707 $t Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association $x 1439-3646 $g Roč. 130, č. 2 (2022), s. 85-93
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32722819 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506130510 $b ABA008
- 999 __
- $a ok $b bmc $g 1788966 $s 1162339
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 130 $c 2 $d 85-93 $e 20200728 $i 1439-3646 $m Experimental and clinical endocrinology & diabetes $n Exp Clin Endocrinol Diabetes $x MED00009707
- GRA __
- $a Ministry of Health of the Czech Republic $p NV18-01-00078
- LZP __
- $a Pubmed-20220425
